Double-Shot defense: can a new vaccine strategy protect cancer patients from deadly infections?

This study tested a two-vaccine strategy to prevent serious pneumococcal infections, like pneumonia, in adults with a type of blood cancer (DLBCL) who were receiving chemotherapy. Researchers wanted to see if giving two different vaccines in a specific order, and testing different doses, could better protect these high-risk patients. The trial involved 26 participants and aimed to find the most effective timing and dosing for vaccination during cancer treatment.